Ruxolitinib add-on therapy in steroid-refractory graft-vs-host disease following hematopoietic cell transplantation: A single institutional experience

• Yi-Lun Wang,
• Tsung-Yen Chang,
• Yu-Chuan Wen,
• Shu-Ho Yang,
• Yi-Wen Hsiao,
• Shih-Hsiang Chen,
• Tang-Her Jaing

Affiliations

Yi-Lun Wang

Division of Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan

Tsung-Yen Chang

Division of Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan

Yu-Chuan Wen

Department of Nursing, Chang Gung Memorial Hospital, Taoyuan, Taiwan

Shu-Ho Yang

Department of Nursing, Chang Gung Memorial Hospital, Taoyuan, Taiwan

Yi-Wen Hsiao

Department of Nursing, Chang Gung Memorial Hospital, Taoyuan, Taiwan

Shih-Hsiang Chen

Division of Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan

Tang-Her Jaing

Division of Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan; Corresponding author. Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University 5 Fu-Shin Street, Kwei-Shan, 333, Taoyuan, Taiwan.